Prescription drug · ANDA
Ery-Tab (Erythromycin) NDC 24338-122
Erythromycin 250 mg/1 · Tablet, Delayed release · Oral · Arbor Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 24338-122-03 | 24338012203 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (24338-122-03)Marketed from Nov 17, 2017 | |
| 24338-122-13 | 24338012213 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (24338-122-13)Marketed from Apr 18, 2011 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ery-Tab
- Generic name (nonproprietary)
- erythromycin
- Active ingredients
- Erythromycin — 250 mg/1
- Dosage form
- Tablet, Delayed release
- Route
- Oral
- Labeler
- Arbor Pharmaceuticals, Inc.NDC labeler code 24338
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 062298
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Sebaceous Gland Activity (Physiologic effect)Macrolides (Chemical structure)
- Identifiers
- Product ID 24338-122_f7f33758-f601-4397-baa4-30286a9a3a39SPL ID f7f33758-f601-4397-baa4-30286a9a3a39SPL set ID fda44eb6-7901-4b80-ba0b-216f6cacf3fdRxCUI 206075, 206078, 206080, 310155, 310157, 315090UNII 63937KV33D
- Pharmacologic class
- Macrolide Antimicrobial; Macrolide
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N424338012203followed by a unit qualifier and the quantityPackage 24338-0122-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of ERY-TAB ® and other antibacterial drugs, ERY-TAB ® should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ERY-TAB ® tablets are indicated in the treatment of infections caused by susceptible strains of the designated microorganisms in the diseases listed be…
Excerpt only. Read the full label for complete information.
About NDC 24338-122
- What is NDC 24338-122?
- 24338-122 is the product NDC for Ery-Tab (erythromycin), Erythromycin 250 mg/1 tablet, delayed release, listed with the FDA by Arbor Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Ery-Tab (Erythromycin).
- What is the active ingredient?
- Erythromycin.
- Who is the labeler?
- Arbor Pharmaceuticals, Inc., NDC labeler code 24338. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Ery-Tab?
- 2 other product NDCs are listed under this name. See all Ery-Tab NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Ery-Tab products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Ery-Taberythromycin | Erythromycin 333 mg/1 | Tablet, Delayed releaseOral | Arbor Pharmaceuticals, Inc. | 24338-124 | 24338-0124-0324338-0124-13 |
| Ery-Taberythromycin | Erythromycin 500 mg/1 | Tablet, Delayed releaseOral | Arbor Pharmaceuticals, Inc. | 24338-126 | 24338-0126-0324338-0126-13 |
Other NDCs under ANDA 062298
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Erythromycin | Erythromycin 333 mg/1 | Tablet, Delayed releaseOral | Wilshire Pharmaceuticals | 52536-183 |
| Erythromycin | Erythromycin 500 mg/1 | Tablet, Delayed releaseOral | Wilshire Pharmaceuticals | 52536-186 |
| Erythromycin | Erythromycin 250 mg/1 | Tablet, Delayed releaseOral | Wilshire Pharmaceuticals | 52536-180 |
| Ery-Taberythromycin | Erythromycin 333 mg/1 | Tablet, Delayed releaseOral | Arbor Pharmaceuticals, Inc. | 24338-124 |
| Ery-Taberythromycin | Erythromycin 500 mg/1 | Tablet, Delayed releaseOral | Arbor Pharmaceuticals, Inc. | 24338-126 |